Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -15.33% is in line with its 5-year average of -16.85%, near the high end of its 5-year range (-95.07%–15.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 77.40% above its 12-month average of -67.84%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -15.33%.
RETURN ON EQUITY (ROE)
-15.33%
RETURN ON EQUITY (ROE) AVG TTM
-67.84%
RETURN ON EQUITY (ROE) AVG 3Y
-24.40%
RETURN ON EQUITY (ROE) AVG 5Y
-16.85%
RETURN ON EQUITY (ROE) AVG 10Y
-32.71%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+77.40%
CURRENT VS 3Y AVG
+37.16%
CURRENT VS 5Y AVG
+9.02%
CURRENT VS 10Y AVG
+53.12%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+63.50%
vs the sector median at left
Prothena Corporation plc
Market Cap
$417.78M
Return on Equity (ROE)
-15.33%
TTM Avg
-67.84%
3Y Avg
-24.40%
5Y Avg
-16.85%
Market Cap
$419.61M
Return on Equity (ROE)
-121.12%
TTM Avg
180.84%
3Y Avg
-1331.02%
5Y Avg
-839.91%
Market Cap
$420.49M
Return on Equity (ROE)
-70.24%
TTM Avg
-381.56%
3Y Avg
-217.03%
5Y Avg
-155.40%
Market Cap
$412.91M
Return on Equity (ROE)
-65.99%
TTM Avg
-51.25%
3Y Avg
-81.12%
5Y Avg
-81.12%
Market Cap
$422.75M
Return on Equity (ROE)
-1721.80%
TTM Avg
-73.40%
3Y Avg
-45.77%
5Y Avg
-18.46%
Market Cap
$423.92M
Return on Equity (ROE)
-38.32%
TTM Avg
-35.34%
3Y Avg
12.60%
5Y Avg
10.50%
Market Cap
$424.40M
Return on Equity (ROE)
-9.23%
TTM Avg
-76.14%
3Y Avg
-50.80%
5Y Avg
-36.67%
Market Cap
$409.72M
Return on Equity (ROE)
-77.06%
TTM Avg
-61.48%
3Y Avg
-56.03%
5Y Avg
-55.28%
Market Cap
$409.69M
Return on Equity (ROE)
14.40%
TTM Avg
1.26%
3Y Avg
-7.83%
5Y Avg
-9.02%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $417.78M | -15.33% | -67.84% | -24.40% | -16.85% |
| Senseonics Holdings, Inc. (SENS)vs › | $419.61M | -121.12% | 180.84% | -1331.02% | -839.91% |
| Editas Medicine, Inc. (EDIT)vs › | $420.49M | -70.24% | -381.56% | -217.03% | -155.40% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $412.91M | -65.99% | -51.25% | -81.12% | -81.12% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $422.75M | -1721.80% | -73.40% | -45.77% | -18.46% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $423.92M | -38.32% | -35.34% | 12.60% | 10.50% |
| Tilray Brands, Inc. (TLRY)vs › | $424.40M | -9.23% | -76.14% | -50.80% | -36.67% |
| Rezolute, Inc. (RZLT)vs › | $409.72M | -77.06% | -61.48% | -56.03% | -55.28% |
| Strata Critical Medical, Inc. (SRTA)vs › | $409.69M | 14.40% | 1.26% | -7.83% | -9.02% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $409.29M | -69.06% | 36.89% | 36.89% | 36.89% |
ROE
-15.3%
ROA
-14.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -15.33% |
| 2026-03-31 | -48.36% |
| 2025-12-31 | -87.03% |
| 2025-09-30 | -95.07% |
| 2025-06-30 | -93.40% |
| 2025-03-31 | -25.19% |
| 2024-12-31 | -25.12% |
| 2024-09-30 | -24.67% |
| 2024-06-30 | -8.75% |
| 2024-03-31 | -34.32% |
| 2023-12-31 | -26.19% |
| 2023-09-30 | -11.86% |
| 2023-06-30 | -24.22% |
| 2023-03-31 | -20.99% |
| 2022-12-31 | -18.80% |
| 2022-09-30 | -38.67% |
| 2022-06-30 | -0.36% |
| 2022-03-31 | 15.36% |
| 2021-12-31 | 14.37% |
| 2021-09-30 | 14.16% |
| 2021-06-30 | -24.42% |
| 2021-03-31 | -52.99% |
| 2020-12-31 | -60.40% |
| 2020-09-30 | -48.68% |
| 2020-06-30 | -38.75% |
| 2020-03-31 | -31.52% |
| 2019-12-31 | -28.46% |
| 2019-09-30 | -27.18% |
| 2019-06-30 | -27.64% |
| 2019-03-31 | -40.93% |
| 2018-12-31 | -48.19% |
| 2018-09-30 | -53.27% |
| 2018-06-30 | -58.64% |
| 2018-03-31 | -40.68% |
| 2017-12-31 | -37.63% |
| 2017-09-30 | -34.60% |
| 2017-06-30 | -29.82% |
| 2017-03-31 | -33.85% |
| 2016-12-31 | -43.82% |
| 2016-09-30 | -33.75% |
| 2016-06-30 | -26.71% |
| 2016-03-31 | -19.95% |
| 2015-12-31 | -22.35% |
| 2015-09-30 | -18.41% |
| 2015-06-30 | -15.12% |
| 2015-03-31 | -14.49% |
| 2014-12-31 | -2.47% |
| 2014-09-30 | -1.69% |
| 2014-06-30 | -0.54% |
| 2014-03-31 | -7.35% |
| 2013-12-31 | -23.66% |
| 2013-09-30 | -42.68% |
| 2013-06-30 | -38.37% |
| 2013-03-31 | -33.58% |
| 2012-12-31 | -32.74% |
